Temporal Trends in the Utilization of Noninvasive Diagnostic Tests for Coronary Artery Disease in Ontario Between 2008 and 2014: A Population-Based Study

• Published in: Canadian journal of cardiology Vol. 33; no. 2; pp. 279 - 282
• Main Authors: Roifman, Idan, MD, Wijeysundera, Harindra C., MD, PhD, Austin, Peter C., PhD, Maclagan, Laura C., MSc, Rezai, Mohammad R., MD, PhD, Wright, Graham A., PhD, Tu, Jack V., MD, PhD
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01-02-2017
• Subjects: Cardiovascular; Coronary Artery Disease - diagnosis; Coronary Artery Disease - epidemiology; Cross-Sectional Studies; Echocardiography, Stress - utilization; Exercise Test - utilization; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Perfusion Imaging - utilization; Ontario - epidemiology; Population Surveillance; Predictive Value of Tests; Prevalence; Retrospective Studies; Time Factors; Tomography, X-Ray Computed - utilization
• ISSN: 0828-282X; 1916-7075
• DOI: 10.1016/j.cjca.2016.07.590

Abstract The proliferation of cardiac diagnostic tests over the past few decades has received substantial attention from policymakers. However, contemporary population-based temporal trends of the utilization of noninvasive cardiac diagnostic tests for coronary artery disease are not known. Our objective was to examine the temporal trends in the utilization of coronary computed tomography angiography (CCTA), myocardial perfusion imaging (MPI), exercise stress testing (GXT), and stress echocardiography between 2008 and 2014. We performed a population-based repeated cross-sectional study of the adult population of Ontario between January 1, 2008 and December 31, 2014. Annual utilization rates of noninvasive cardiac diagnostic tests were computed. For each cardiac testing modality, a negative binomial regression model was used to assess temporal changes in test utilization. GXT and MPI collectively accounted for 88% of all cardiac noninvasive diagnostic tests throughout our study period. Age- and sex-standardized rates of GXT declined from 26.7/1000 adult population to 21.6/1000 adult population (mean annual reduction of 3.4%; P < 0.001). MPI rates declined from 21.1/1000 adult population to 19.5/1000 adult population (mean annual reduction of 1.3%; P < 0.001). Although utilization rates for both CCTA and stress echocardiography increased over time, the combined rate of all available tests decreased from 50.8/1000 adult population to 49.1/1000 adult population (mean annual reduction of 1.1%; P < 0.001). In conclusion, utilization rates for the most prevalent noninvasive cardiac diagnostic tests—GXT and MPI—declined over our study period. Furthermore, the overall test utilization rate also declined over time. We believe our findings are encouraging from a health policy perspective. Nonetheless, rising utilization rates for CCTA and stress echocardiography will need to be monitored in the future.